Telemetric intracranial pressure (ICP) monitoring is a new method of measuring ICP which eliminates some of the shortcomings of previous methods. However, there are limited data on specific characteristics, including the advantages and disadvantages of this method. The main aim of this study was to demonstrate the indications, benefits, and complications of telemetric ICP monitoring. PubMed, MEDLINE, EMBASE, and the Cochrane Central Register of Controlled Trials were searched for relevant studies without language or date restriction in May 2019. Human studies in which telemetric ICP monitoring was the main subject of the study were included. Our initial search resulted in 1650 articles from which 50 studies were included. There were no randomized controlled trials. The majority of the studies were case reports or case series (68%). The most common aim of studies was testing of the device (52%), and monitoring the disease progression or recovery (46%). The most common indications for telemetric ICP monitoring in these studies were testing cerebrospinal fluid shunt function (46%), ICP control after the procedure (36%), and diagnosing intracranial hypertension (22%) and hydrocephalus (12%). In total, 1423 brain disease patients had been monitored in studies. The possibility of long-term ICP monitoring as the main benefit was reported in 38 (76%) studies. The associated complication rate was 7.1%. Despite the increasing application of telemetric monitoring devices, studies to evaluate specific characteristics of this method have been infrequent and inadequate. Future research using a higher level of scientific methods is needed to evaluate advantage and disadvantages.

中文翻译：

---

遥测颅内压监测：系统评价。

遥测颅内压 (ICP) 监测是一种测量 ICP 的新方法，它消除了以前方法的一些缺点。然而，关于具体特征的数据有限，包括这种方法的优点和缺点。本研究的主要目的是证明遥测 ICP 监测的适应症、益处和并发症。2019 年 5 月，在 PubMed、MEDLINE、EMBASE 和 Cochrane Central Register of Controlled Trials 中搜索了相关研究，没有语言或日期限制。其中以遥测 ICP 监测为主要研究对象的人类研究被纳入。我们最初的搜索结果是 1650 篇文章，其中包括 50 项研究。没有随机对照试验。大多数研究是病例报告或病例系列（68%）。最常见的研究目的是测试设备 (52%) 和监测疾病进展或恢复 (46%)。在这些研究中，遥测 ICP 监测的最常见指征是测试脑脊液分流功能 (46%)、手术后的 ICP 控制 (36%) 以及诊断颅内高压 (22%) 和脑积水 (12%)。研究中总共监测了 1423 名脑部疾病患者。38 项（76%）研究报告了将长期 ICP 监测作为主要益处的可能性。相关并发症发生率为 7.1%。尽管遥测监测设备的应用越来越多，但评估这种方法的特定特性的研究并不频繁且不充分。未来的研究需要使用更高水平的科学方法来评估优势和劣势。